학술논문
P2.06-029 Pilot Window-Of-Opportunity Study of Pembrolizumab in Patients with Resectable Malignant Pleural Mesothelioma (MPM): Topic: Mesothelioma and SCLC
Document Type
Abstract
Author
Source
In Journal of Thoracic Oncology January 2017 12(1) Supplement:S1089-S1089
Subject
Language
ISSN
1556-0864